Becton Dickinson and

AI Score

0

Unlock

231.71
4.50 (1.98%)
At close: Feb 10, 2025, 12:11 PM
undefined%
Bid 231.55
Market Cap 66.53B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 5.93
PE Ratio (ttm) 39.07
Forward PE n/a
Analyst Buy
Ask 231.72
Volume 794,065
Avg. Volume (20D) 2,111,525
Open 229.85
Previous Close 227.21
Day's Range 229.53 - 234.41
52-Week Range 218.75 - 251.99
Beta undefined

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and pr...

Sector Healthcare
IPO Date Feb 21, 1973
Employees 70,000
Stock Exchange NYSE
Ticker Symbol BDX

Analyst Forecast

According to 7 analyst ratings, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $277.5, which is an increase of 19.76% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Becton Dickinson and is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
-7.28%
Becton, Dickinson and Company shares are trading l... Unlock content with Pro Subscription
5 days ago
+1.09%
Becton, Dickinson and Company shares are trading lower following Q1 financial results.